Cargando…
Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression
To this end human MSCs were isolated from adipose tissue and the MSC:CD4(+) T-cell suppression was assessed in a co-culture system. In summary, this study demonstrates that advanced age, atherosclerosis and type 2 diabetes mellitus reduce the functional potency of MSCs. Optimizing the criteria for t...
Autores principales: | Kizilay Mancini, Ozge, Shum-Tim, Dominique, Stochaj, Ursula, Correa, José A., Colmegna, Inés |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529693/ https://www.ncbi.nlm.nih.gov/pubmed/26253429 http://dx.doi.org/10.1186/s13287-015-0127-9 |
Ejemplares similares
-
Erratum to: Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression
por: Mancini, Ozge Kizilay, et al.
Publicado: (2017) -
A Proinflammatory Secretome Mediates the Impaired Immunopotency of Human Mesenchymal Stromal Cells in Elderly Patients with Atherosclerosis
por: Kizilay Mancini, Özge, et al.
Publicado: (2017) -
MSC - targets for atherosclerosis therapy
por: Colmegna, Ines, et al.
Publicado: (2018) -
CD26 is a senescence marker associated with reduced immunopotency of human adipose tissue-derived multipotent mesenchymal stromal cells
por: Psaroudis, Rose Triantafillia, et al.
Publicado: (2022) -
Human multipotent mesenchymal stromal cells cytokine priming promotes RAB27B-regulated secretion of small extracellular vesicles with immunomodulatory cargo
por: Cheng, Anastasia, et al.
Publicado: (2020)